The FDA approved vorasidenib (Voranigo) on August 6, 2024 — a targeted therapy for IDH-mutant low-grade glioma, a type of brain cancer most commonly diagnosed…
World Brain Tumor Day is observed on June 8 every year to raise awareness and educate people about brain tumors. In 2000, it was first…
We actively pursue new drug combination clinical trials for brain tumor patients. The newly developed Phase 0 platform combined with precision medicine allows us to…
What’s the treatment for GBM? The standard of treatment for a GBM is surgery, followed by daily radiation and oral chemotherapy for six and a half…
**Building a Supportive Glioblastoma Network: Together We Are Stronger** Facing a diagnosis of Glioblastoma can feel overwhelming, but having a strong support network can make…
Glioblastoma, a formidable brain cancer, has long presented a challenging frontier in oncology due to its aggressive nature and resistance to conventional treatments. However, recent…
Glioblastoma, an aggressive form of brain cancer, casts a disproportionate shadow across various racial groups in the United States, revealing stark disparities in both incidence…